Valentina Hoyos Velez, M.D.
Baylor College of Medicine
|Titles & Positions|
|Grant ID: RR170024|
Recruitment of First-Time, Tenure-Track Faculty Members
Johns Hopkins University
May 17, 2017
Chimeric antigen receptors are genetically modified T-cells, created by engineering a patient’s own immune cells so they can seek out and bind to cancer cells and kill them. CAR T-cell immune therapy has proven successful for some blood cancers but solid tumors present additional challenges.
Now an oncologist at Baylor College of Medicine is exploring ways of engineering T-cells to successfully attack solid tumors like breast cancer. Physician-scientist Dr. Valentina Hoyos Velez, M.D., was recruited in 2017 from Johns Hopkins University where she was a clinical fellow in hematology and oncology. She previously was a resident at Baylor and received a First-Time Tenure-Track Award from CPRIT to facilitate her return to Texas.